Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Brian Seal"'
Publikováno v:
Hepatic Oncology, Vol 10, Iss 1 (2023)
Aim: Many pivotal trials in advanced hepatocellular carcinoma (HCC) require participants to have Child-Pugh A disease. However, many patients in real-world practice are Child-Pugh B or C. This study examined treatment patterns and clinical outcomes i
Externí odkaz:
https://doaj.org/article/a2f116b05da54d588fed8e4939c6776b
Autor:
Anna Hung, Kyung Min Lee, Julie A. Lynch, Yanhong Li, Pradeep Poonnen, Olga V. Efimova, Bradley J. Hintze, Trudy Buckingham, Candice Yong, Brian Seal, Michael J. Kelley, Shelby D. Reed
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background The Veterans Health Administration (VHA) is the largest integrated health care system in the United States (US). Among VHA patients, the rate of use of concurrent chemoradiation therapy (CCRT) among those with unresectable, stage
Externí odkaz:
https://doaj.org/article/750fdfa47ed44f2a96ca37f437898721
Publikováno v:
Cancer Reports, Vol 5, Iss 5, Pp n/a-n/a (2022)
Abstract Background Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer with increasing incidence and mortality worldwide. For metastatic disease, systemic treatment is recommended. In addition to tumor characteristics, adverse event
Externí odkaz:
https://doaj.org/article/89b2aec8210a4f429be82335e0823f77
Autor:
Ryan N. Hansen, Yiduo Zhang, Brian Seal, Kellie Ryan, Candice Yong, Annie Darilay, Scott D. Ramsey
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background To evaluate the value of new therapies for non-small cell lung cancer (NSCLC), it is necessary to understand overall survival (OS) rates associated with previous standard therapies and how these rates have evolved over time. Metho
Externí odkaz:
https://doaj.org/article/0d217e2bbdb0491899008657036c9fd1
Publikováno v:
Hepatic Oncology, Vol 8, Iss 3 (2021)
Aim: To examine the locoregional therapy (LRT) patterns and the healthcare economic burden of patients with hepatocellular carcinoma (HCC) in the USA. Patients & methods: Patients with newly diagnosed HCC were identified from the MarketScan® databas
Externí odkaz:
https://doaj.org/article/1aa971b12975498494c7895c073279af
Autor:
Eberechukwu Onukwugha, Young Kwok, Jay P Ciezki, Candice Yong, Catherine Plaisant, Chandana A Reddy, C Daniel Mullins, Brian Seal, Adriana Valderrama, Arif Hussain
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175956 (2017)
Purpose/objective(s)Skeletal-related events (SREs), which include radiation to the bone (RtB), can occur among patients with bone metastasis (BM). There is a recognized potential for misclassification of RtB when using claims data. We compared altern
Externí odkaz:
https://doaj.org/article/db737d33cc72479c8c019e0c4a820fa9
Autor:
Anita Burrell, Zsombor Zrubka, Annette Champion, Vladimir Zah, Laura Vinuesa, Anke-Peggy Holtorf, Rossella Di Bidino, Jagadeswara Rao Earla, Joanna Entwistle, Artem Tarasovic Boltyenkov, George Braileanu, Katarzyna Kolasa, Jessica Roydhouse, Carl Asche, Ken Redekop, Colin Pfeiffer, Long Le, Manthan Janodia, Menna Sharkawy, Mete Şaylan, Sang-Soo Lee, Sean Glynn, Arijit Ganguli, Sherif Badawy, Luiz Sérgio Carvalho, Fredric Ernst, Brian Seal, Cecile van Steen, Naiya Patel, Hailey Lee, Abigail Doe, Lisa Strouss, Luigi Angelillo, Chad Patel, Sanjoy Paul
Publikováno v:
Value in Health. 25:1469-1479
This study aimed to review definitions of digital health and understand their relevance for health outcomes research. Four umbrella terms (digital health, electronic health, mobile health, and telehealth/telemedicine) were summarized in this article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63ce833d65ab17dde30e2238c3b1f74
https://doi.org/10.1016/j.jval.2022.04.1730
https://doi.org/10.1016/j.jval.2022.04.1730
Autor:
Andrew J, Klink, Landon Z, Marshall, Abdalla, Aly, Brian, Seal, Marcus J, Healey, Bruce, Feinberg
Publikováno v:
The Oncologist. 27:e265-e272
Background The treatment landscape for advanced hepatocellular carcinoma (aHCC) is rapidly expanding beyond tyrosine kinase inhibitors (TKIs) in the first-line (1L) setting, with multiple TKIs and immune-checkpoint inhibitors (ICIs) now being evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::141a5914897f38d7affe4ac5d43d2ad8
https://doi.org/10.1093/oncolo/oyab059
https://doi.org/10.1093/oncolo/oyab059
Autor:
Brian Seal, Candice Yong, Trudy Buckingham, Anna Hung, Kyung Min Lee, Michael J. Kelley, Bradley J. Hintze, Yanhong Li, Shelby D. Reed, Julie Lynch, Olga V. Efimova, Pradeep J. Poonnen
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
BackgroundThe Veterans Health Administration (VHA) is the largest integrated health care system in the United States (US). Among VHA patients, the rate of use of concurrent chemoradiation therapy (CCRT) among those with unresectable, stage III non-sm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505afe68fe14854303f36891a1c1de66
https://doaj.org/article/750fdfa47ed44f2a96ca37f437898721
https://doaj.org/article/750fdfa47ed44f2a96ca37f437898721
Autor:
Marcus J. Healey, Brian Seal, Nicole Princic, Danae Black, Elisabetta Malangone-Monaco, Nilofer S. Azad, Rory L. Smoot
Publikováno v:
Advances in therapy. 39(12)
People with advanced biliary tract cancers (BTCs) have a 5-year survival of approximately 2% in the USA. Most cases are inoperable or require systemic treatment following surgery. This study adds to current literature by describing treatment patterns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e618492658e141b7d2199fd0142306c6
https://pubmed.ncbi.nlm.nih.gov/36241962
https://pubmed.ncbi.nlm.nih.gov/36241962